Clinical activity and cardiac tolerability of non-pegylated liposomal doxorubicin in breast cancer: A synthetic review

Mario Airoldi, Dino Amadori, Sandro Barni, Saverio Cinieri, Sabino De Placido, Angelo Di Leo, Alessandra Gennari, Stefano Iacobelli, Maria Teresa Ionta, Vito Lorusso, Marzia Lotrionte, Paolo Marchetti, Rodolfo Mattioli, Giorgio Minotti, Paolo Pronzato, Giovanni Rosti, Carlo Alberto Tondini, Andrea Veronesi

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)690-692
Number of pages3
JournalTumori
Volume97
Issue number6
DOIs
Publication statusPublished - Nov 2011

Keywords

  • Breast cancer
  • Non-pegylated liposomal doxorubicin

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Airoldi, M., Amadori, D., Barni, S., Cinieri, S., De Placido, S., Leo, A. D., Gennari, A., Iacobelli, S., Ionta, M. T., Lorusso, V., Lotrionte, M., Marchetti, P., Mattioli, R., Minotti, G., Pronzato, P., Rosti, G., Tondini, C. A., & Veronesi, A. (2011). Clinical activity and cardiac tolerability of non-pegylated liposomal doxorubicin in breast cancer: A synthetic review. Tumori, 97(6), 690-692. https://doi.org/10.1700/1018.11082